Cargando…
Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
To assess the potential of individual bile acids (IBA) and their profiles as mechanistic biomarkers of liver injury for humans in real world situations, we interrogated samples collected under minimum controlled conditions (ie subjects were not fasted). Total bile acids (TBA) have been considered to...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841799/ https://www.ncbi.nlm.nih.gov/pubmed/29513725 http://dx.doi.org/10.1371/journal.pone.0193824 |
_version_ | 1783304800179322880 |
---|---|
author | Luo, Lina Aubrecht, Jiri Li, Dingzhou Warner, Roscoe L. Johnson, Kent J. Kenny, Julia Colangelo, Jennifer L. |
author_facet | Luo, Lina Aubrecht, Jiri Li, Dingzhou Warner, Roscoe L. Johnson, Kent J. Kenny, Julia Colangelo, Jennifer L. |
author_sort | Luo, Lina |
collection | PubMed |
description | To assess the potential of individual bile acids (IBA) and their profiles as mechanistic biomarkers of liver injury for humans in real world situations, we interrogated samples collected under minimum controlled conditions (ie subjects were not fasted). Total bile acids (TBA) have been considered to be biomarkers of liver injury for decades, and more recently, monitoring of IBA has been proposed for differentiation of variety of etiologies of liver injury. We established a LC-MS/MS methodology to analyze nine IBA, generated reference ranges, and examined effects of age, gender, and ethnicity for each IBA. Furthermore, we evaluated the ability of IBA and their profiles to detect hepatic injury in subjects with a broad range of liver impairments. To date, our study utilized the largest total cohort of samples (N = 645) that were divided into 2 groups, healthy or liver impaired, to evaluate IBA as biomarkers. The TBA serum levels in the Asian ethnic group trended higher when compared to other ethnic groups, and the serum concentrations of IBA, such as glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), chenodeoxycholic acid (CDCA), and taurochenoxycholic acid (TCDCA) were significantly increased. To our knowledge, this report is the first to describe ethnic differences in serum concentrations of IBAs. In patients with hepatic impairments, with the exception of deoxycholic acid (DCA), the concentrations of IBAs were significantly elevated when compared with healthy subjects. The conjugated bile acids displayed greater differences between healthy subjects and subjects with hepatic impairments than non-conjugated bile acids. Furthermore, the subjects with hepatic impairments exhibited distinct profiles (signatures) of IBAs that clustered subjects according the nature of their liver impairments. Although additional studies are needed, our data suggested that the analysis of IBA has the potential to become useful for differentiation of various forms of liver injury. |
format | Online Article Text |
id | pubmed-5841799 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-58417992018-03-23 Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans Luo, Lina Aubrecht, Jiri Li, Dingzhou Warner, Roscoe L. Johnson, Kent J. Kenny, Julia Colangelo, Jennifer L. PLoS One Research Article To assess the potential of individual bile acids (IBA) and their profiles as mechanistic biomarkers of liver injury for humans in real world situations, we interrogated samples collected under minimum controlled conditions (ie subjects were not fasted). Total bile acids (TBA) have been considered to be biomarkers of liver injury for decades, and more recently, monitoring of IBA has been proposed for differentiation of variety of etiologies of liver injury. We established a LC-MS/MS methodology to analyze nine IBA, generated reference ranges, and examined effects of age, gender, and ethnicity for each IBA. Furthermore, we evaluated the ability of IBA and their profiles to detect hepatic injury in subjects with a broad range of liver impairments. To date, our study utilized the largest total cohort of samples (N = 645) that were divided into 2 groups, healthy or liver impaired, to evaluate IBA as biomarkers. The TBA serum levels in the Asian ethnic group trended higher when compared to other ethnic groups, and the serum concentrations of IBA, such as glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), chenodeoxycholic acid (CDCA), and taurochenoxycholic acid (TCDCA) were significantly increased. To our knowledge, this report is the first to describe ethnic differences in serum concentrations of IBAs. In patients with hepatic impairments, with the exception of deoxycholic acid (DCA), the concentrations of IBAs were significantly elevated when compared with healthy subjects. The conjugated bile acids displayed greater differences between healthy subjects and subjects with hepatic impairments than non-conjugated bile acids. Furthermore, the subjects with hepatic impairments exhibited distinct profiles (signatures) of IBAs that clustered subjects according the nature of their liver impairments. Although additional studies are needed, our data suggested that the analysis of IBA has the potential to become useful for differentiation of various forms of liver injury. Public Library of Science 2018-03-07 /pmc/articles/PMC5841799/ /pubmed/29513725 http://dx.doi.org/10.1371/journal.pone.0193824 Text en © 2018 Luo et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Luo, Lina Aubrecht, Jiri Li, Dingzhou Warner, Roscoe L. Johnson, Kent J. Kenny, Julia Colangelo, Jennifer L. Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans |
title | Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans |
title_full | Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans |
title_fullStr | Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans |
title_full_unstemmed | Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans |
title_short | Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans |
title_sort | assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841799/ https://www.ncbi.nlm.nih.gov/pubmed/29513725 http://dx.doi.org/10.1371/journal.pone.0193824 |
work_keys_str_mv | AT luolina assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans AT aubrechtjiri assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans AT lidingzhou assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans AT warnerroscoel assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans AT johnsonkentj assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans AT kennyjulia assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans AT colangelojenniferl assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans |